To further unravel the intricate relationship between drug binding sites and their protein targets in the context of chromatin states, we performed scEpiChem, including ATAC modality with human CRC organoids by simultaneously measuring JQ1-btn, BRD4 and ATAC (Extended Data Fig. 6j). This evidence concerns the gene BRD4 and colorectal carcinoma.